Stay updated on Elranatamab in Refractory Multiple Myeloma Clinical Trial

Sign up to get notified when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Elranatamab in Refractory Multiple Myeloma Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    Revision v3.5.2 was added to the history, and Revision v3.5.0 was removed.
    Difference
    0.1%
    Check dated 2026-04-16T11:08:04.000Z thumbnail image
  2. Check
    7 days ago
    No Change Detected
  3. Check
    14 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    Change Detected
    Summary
    Revision v3.5.0 was added to the Record History and revision v3.4.3 was removed.
    Difference
    0.1%
    Check dated 2026-03-18T18:12:51.000Z thumbnail image
  6. Check
    36 days ago
    Change Detected
    Summary
    Added Revision: v3.4.3 and removed Revision: v3.4.2 from the history, indicating a site version update.
    Difference
    0.1%
    Check dated 2026-03-11T15:53:54.000Z thumbnail image
  7. Check
    65 days ago
    Change Detected
    Summary
    The page shows an added Revision: v3.4.2 and the removal of prior notices including the lapse-in-funding message and the v3.4.1 revision notice. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-11T02:11:50.000Z thumbnail image
  8. Check
    72 days ago
    Change Detected
    Summary
    A site-wide notice about government funding and operating status was added. The page version was updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-03T23:49:11.000Z thumbnail image
  9. Check
    79 days ago
    Change Detected
    Summary
    Glossary visibility is added and color-coded indicators (green for additions and red for deletions) along with current revision metadata (Revision: v3.4.0) are now displayed. The previously displayed No FEAR Act data and older Revision: v3.3.4 have been removed.
    Difference
    0.5%
    Check dated 2026-01-28T00:23:50.000Z thumbnail image

Stay in the know with updates to Elranatamab in Refractory Multiple Myeloma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Elranatamab in Refractory Multiple Myeloma Clinical Trial page.